Milani Nasrin, Darband Tayyebeh Jalayernia, Mousa-Farkhani Ehsan, Goshayeshi Ladan, Kabiri Mona
Department of Internal Medicine, Faculty of Medicine, Mashhad University of Medical Sciences, Mashhad, Iran.
Department of Family Medicine, Faculty of Medicine, Mashhad University of Medical Sciences, Mashhad, Iran.
Middle East J Dig Dis. 2023 Oct;15(4):249-256. doi: 10.34172/mejdd.2023.354. Epub 2023 Oct 30.
Colorectal cancer (CRC) is the most prevalent cancer with high mortality worldwide. We aimed to evaluate the incidence of CRC based on the positive fecal immunochemical test (FIT) result in the Iranian population. The present study was conducted on the health assessment data recorded in the SINA (Integrated Health Information System) in 2018 and 2019 from individuals who had participated in the national program, including asymptomatic people aged 50-69 years or had risk factors of CRC such as family or past personal history of CRC as well as symptomatic individuals, for the early detection and prevention of CRC in Mashhad, Iran. The study participants included 140,463 eligible individuals, of whom 8258 (5.88%) and 145 (2.21%) were positive for FIT and diagnosed with colon cancer, respectively. Unfortunately, only 654 people had undergone colonoscopy. Our results indicated that age, fast food intake (≥two units per day), family history of CRC in first or second-degree relatives, some gastrointestinal diseases such as inflammatory bowel disease (IBD) and CRC, as well as bleeding per anus, constipation, abdominal cramp, and losing body weight were associated with increased risk of positive FIT. However, some other factors, including having a hard job, physical activity, and Iranian nationality (compared to non-Iranians), were associated with a low risk of positive FIT screening tests for CRC. A high number of high-risk persons in Mashhad were positive for the FIT test in 2018-2019, and many of them were diagnosed with CRC, according to the colonoscopy results. Therefore, screening is highly recommended as the first step in the early detection of CRC.
结直肠癌(CRC)是全球范围内最常见且死亡率高的癌症。我们旨在基于粪便免疫化学检测(FIT)阳性结果评估伊朗人群中结直肠癌的发病率。本研究针对2018年和2019年记录在伊朗马什哈德的SINA(综合健康信息系统)中的健康评估数据展开,这些数据来自参与国家项目的人群,包括50 - 69岁的无症状个体、有结直肠癌风险因素(如结直肠癌家族史或个人既往史)的个体以及有症状的个体,目的是早期发现和预防结直肠癌。研究参与者包括140463名符合条件的个体,其中8258人(5.88%)FIT检测呈阳性,分别有145人(2.21%)被诊断为结肠癌。遗憾的是,只有654人接受了结肠镜检查。我们的结果表明,年龄、快餐摄入量(每天≥两份)、一级或二级亲属的结直肠癌家族史、一些胃肠道疾病(如炎症性肠病(IBD)和结直肠癌)以及肛门出血、便秘、腹部绞痛和体重减轻与FIT检测呈阳性的风险增加相关。然而,其他一些因素,包括从事高强度工作、体育活动以及伊朗国籍(与非伊朗人相比),与结直肠癌FIT筛查检测呈阳性的低风险相关。根据结肠镜检查结果,2018 - 2019年马什哈德有大量高危人群FIT检测呈阳性,其中许多人被诊断为结直肠癌。因此,强烈建议将筛查作为结直肠癌早期检测的第一步。